secwatch.observer — SEC 8-K summary
======================================

Issuer:     PROKIDNEY CORP. (PROK)
CIK:        0001850270
Form:       8-K
Filed at:   2025-07-14T23:59:59+00:00
Accession:  0001193125-25-158806
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 1.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ProKidney enters new $200M ATM equity facility with Jefferies, terminates prior agreement
--------------------------------------------------------------------------------

- New Open Market Sale Agreement with Jefferies LLC allows sale of up to $200M of Class A common stock.
- Jefferies will receive up to 3.0% compensation of gross proceeds from any sales under the agreement.
- Prior $200M ATM agreement dated Jan 19, 2024 was mutually terminated effective July 14, 2025.
- Company has no obligation to sell shares; sales may occur through various methods including Nasdaq.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1850270/000119312525158806/0001193125-25-158806-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1850270/000119312525158806/d918608d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-158806

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer